TEANECK, N.J., April 23, 2012 /PRNewswire/ -- Herborium
Group, Inc., (Pink Sheets: HBRM) www.herborium.com, a Botanical
Therapeutics® company, announced today that the Board of
Directors of the Company has approved a new share buyback program.
As the first step of the buyback program the Board authorized
the Company to buy back up to 100 million of its common shares in
the open market, in 2012. Herborium Group, Inc. has announced this
large first step of the buyback plan to increase the value to the
shareholders and to tighten up Herborium's free trading float as
all shares repurchased under the program are retired.
Dr. Agnes Olszewski, Herborium's
Chairmen and CEO stated: "We are most excited to confirm our
commitment to increasing shareholder value beginning at the
foundations, our share structure. Herborium very much values our
loyal shareholders and this is just the beginning of a new chapter
in our transparent communication with them and appreciation of them
and their patience during some very complex deal executions. The
share buyback is also the first of several material steps as
Herborium prepares itself for up listing to the OTCQB and beyond as
2012 shall prove to be our most exciting year yet!"
The size and timing of these purchases will depend on price,
market and business conditions and other factors.
About Herborium Group, Inc.
Herborium Group, Inc., a Botanical Therapeutics® company,
focuses on developing, licensing, and marketing proprietary,
botanical based medicinal products to consumers and healthcare
professionals. The Company uses clinical validation to establish
and maintain a differential advantage. The company sales its
products in the US and Europe. For
more information, please visit www.herborium.com and
www.acnease.com.
One of our most important responsibilities is to communicate
with shareholders in an open and direct manner. Comments are based
on current management expectations, and are considered
"forward-looking statements," generally preceded by words such as
"plans," "expects," "believes," "anticipates," or "intends." We
cannot promise future returns. Our statements reflect our best
judgment at the time, and we disclaim any obligation to update or
alter forward-looking statements as the result of new information
or future events. The Company urges investors to review the risks
and uncertainties contained within its filings with the OTC Markets
and/or Securities and Exchange Commission.
For more information please inquire: Herborium Group, Inc.
Investorsrelations@herborium.com
SOURCE Herborium Group, Inc.